Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17937974 | 1.00 | HIF1A (0.47) | HIF1APTGS2NPC1RAB9AALDH1A1 | |
| SCHEMBL13148668 | 1.00 | HIF1A (0.47) | HIF1APTGS2NPC1RAB9AALDH1A1 | |
| SCHEMBL828434 | 1.00 | HIF1A (0.47) | HIF1APTGS2NPC1RAB9AALDH1A1 | |
| SCHEMBL7171768 | 0.92 | HIF1A (0.43) | HIF1APTGS2RAB9AALDH1A1LMNA | |
| SCHEMBL7171770 | 0.92 | HIF1A (0.43) | HIF1APTGS2RAB9AALDH1A1LMNA | |
| SCHEMBL7716053 | 0.91 | HIF1A (0.48) | HIF1APTGS2NPC1RAB9AALDH1A1 | |
| SCHEMBL17937978 | 0.91 | HIF1A (0.42) | HIF1APTGS2NPC1RAB9ALMNA | |
| SCHEMBL7713710 | 0.91 | HIF1A (0.42) | HIF1APTGS2NPC1RAB9ALMNA | |
| SCHEMBL17937973 | 0.91 | HIF1A (0.48) | HIF1APTGS2NPC1RAB9AALDH1A1 | |
| SCHEMBL7716055 | 0.91 | HIF1A (0.48) | HIF1APTGS2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3047731-A1 | Method for combating soybean rust comprising treating soybean with (2E)-2-[3-substituted-2 [[(E)-[(2E)-2-alkoxyimino-1-methyl-2-phenyl-ethylidene]amino]oxymethyl]phenyl]-2-methoxy-imino-N-methyl-acetamides | BASF SE (DE) | 2016-07-27 | — | — | EP | disclosed |
| US-8143275-B2 | Use of triazolopyrimidine derivatives as microbicides | LANXESS DEUTSCHLAND GMBH (DE) | 2012-03-27 | — | — | US | disclosed |
| US-20110098279-A1 | USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-04-28 | — | — | US | disclosed |
| US-7888371-B2 | For protecting engineered wood, timber, or plastic from phytopathogenic fungi | LANXESS DEUTSCHLAND GMBH (DE) | 2011-02-15 | — | — | US | disclosed |
| US-7084137-B2 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2006-08-01 | — | — | US | disclosed |
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-14 | — | — | US | disclosed |
| EP-1437940-A1 | THIAZINES AND THIAZOLES FOR USE AS MATERIAL PROTECTIVE AGENTS | Bayer Chemicals AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| US-20030207929-A1 | 3-nitroisoxazoles and their use in the protection of materials | LANXESS DEUTSCHLAND GMBH (DE) | 2003-11-06 | — | — | US | disclosed |
| US-6638958-B2 | 3-nitroisoxazoles and their use in the protection of materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| US-20030166698-A1 | 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2003-09-04 | — | — | US | disclosed |
| WO-2000064881-A1 | O-ARYL DITHIAZOLE DIOXIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000064895-A1 | HETARYL-SUBSTITUTED DITHIAZOLE DIOXIDES USED AS PLANT PROTECTION AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-02 | — | — | WO | disclosed |
| US-6075019-A | Arylthio-dithiazindioxides and their use as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2000-06-13 | — | — | US | disclosed |
| EP-0982995-A1 | ALGICIDES | Bayer Aktiengesellschaft (DE) | 2000-03-08 | — | — | EP | disclosed |
| WO-1999062911-A1 | PYRIDODITHIAZINE DIOXIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-09 | — | — | WO | disclosed |
| EP-0950055-A1 | ARYLTHIO-DITHIAZINDIOXIDES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998051154-A1 | ALGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998045258-A1 | 1-CYANO-2-ALKYLTHIO-2-ARYLTHIOETHENES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998029400-A1 | ARYLTHIO-DITHIAZINDIOXIDES AND THEIR USE AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-07-09 | — | — | WO | disclosed |
| WO-1997047606-A1 | ARYLOXYACRYLIC ACID ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | POT1, NAT1, GPX1 | HIF1A 2331/4885PTGS2 2032/4885NPC1 555/4885 |
| US-20110098279-A1 | USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES | ARG2, MSR1, TK2 | HIF1A 1989/4885PTGS2 767/4885NPC1 3661/4885 |
| US-20030166698-A1 | 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS | GPX1, NOX1, XDH | HIF1A 541/4885PTGS2 459/4885NPC1 1665/4885 |
| US-20030207929-A1 | 3-nitroisoxazoles and their use in the protection of materials | GPX1, NOX1, XDH | HIF1A 541/4885PTGS2 459/4885NPC1 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.